Shares of vaccine specialist Vaxart have exploded an astonishing 4748% so far this year, as investors have piled into the company on the hopes that it – and its “one-of-its-kind” […]
read moreShares of vaccine specialist Vaxart have exploded an astonishing 4748% so far this year, as investors have piled into the company on the hopes that it – and its “one-of-its-kind” […]
read more